Cargando…

Transplanting Supersites of HIV-1 Vulnerability

One strategy for isolating or eliciting antibodies against a specific target region on the envelope glycoprotein trimer (Env) of the human immunodeficiency virus type 1 (HIV-1) involves the creation of site transplants, which present the target region on a heterologous protein scaffold with preserve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Tongqing, Zhu, Jiang, Yang, Yongping, Gorman, Jason, Ofek, Gilad, Srivatsan, Sanjay, Druz, Aliaksandr, Lees, Christopher R., Lu, Gabriel, Soto, Cinque, Stuckey, Jonathan, Burton, Dennis R., Koff, Wayne C., Connors, Mark, Kwon, Peter D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084637/ https://www.ncbi.nlm.nih.gov/pubmed/24992528 http://dx.doi.org/10.1371/journal.pone.0099881

Ejemplares similares

Correction: Transplanting Supersites of HIV-1 Vulnerability
Publicado: (2014)

Protein—protein binding supersites
por: Viswanathan, Raji, et al.
Publicado: (2019)

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
por: Kong, Leopold, et al.
Publicado: (2013)

An NTD supersite of attack
por: Lok, Shee-Mei
Publicado: (2021)

Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
por: Shi, Wei, et al.
Publicado: (2022)

Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability
por: Shi, Wei, et al.
Publicado: (2022)

Structure and immune recognition of trimeric prefusion HIV-1 Env
por: Pancera, Marie, et al.
Publicado: (2014)

SuperSite: dictionary of metabolite and drug binding sites in proteins
por: Bauer, Raphael André, et al.
Publicado: (2009)

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite
por: Cerutti, Gabriele, et al.
Publicado: (2021)

HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite
por: Nogal, Bartek, et al.
Publicado: (2020)

N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function
por: Pancera, Marie, et al.
Publicado: (2013)

A Cysteine Zipper Stabilizes a Pre-Fusion F Glycoprotein Vaccine for Respiratory Syncytial Virus
por: Stewart-Jones, Guillaume B. E., et al.
Publicado: (2015)

A neutralizing-protective supersite of human monoclonal antibodies for yellow fever virus
por: Li, Yan, et al.
Publicado: (2022)

Somatic Populations of PGT135–137 HIV-1-Neutralizing Antibodies Identified by 454 Pyrosequencing and Bioinformatics
por: Zhu, Jiang, et al.
Publicado: (2012)

Developmental Pathway of the MPER-Directed HIV-1-Neutralizing Antibody 10E8
por: Soto, Cinque, et al.
Publicado: (2016)

Cooperative recruitment of Yan via a high-affinity ETS supersite organizes repression to confer specificity and robustness to cardiac cell fate specification
por: Boisclair Lachance, Jean-François, et al.
Publicado: (2018)

Structural basis for broad neutralization of ebolaviruses by an antibody targeting the glycoprotein fusion loop
por: Janus, Benjamin M., et al.
Publicado: (2018)

Glucose depletion activates mmu-miR-466h-5p expression through oxidative stress and inhibition of histone deacetylation
por: Druz, Aliaksandr, et al.
Publicado: (2012)

A V(H)1-69 antibody lineage from an infected Chinese donor potently neutralizes HIV-1 by targeting the V3 glycan supersite
por: Kumar, Sonu, et al.
Publicado: (2020)

Analysis of two cooperating antibodies unveils immune pressure imposed on HIV Env to elicit a V3-glycan supersite broadly neutralizing antibody lineage
por: Finkelstein, Maxwell T., et al.
Publicado: (2022)

Structural Biology and the Design of Effective Vaccines for HIV-1 and Other Viruses
por: Kwong, Peter D., et al.
Publicado: (2010)

Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape
por: Wibmer, Constantinos Kurt, et al.
Publicado: (2017)

Crystal structure, conformational fixation, and entry-related interactions of mature ligand-free HIV-1 Env
por: Kwon, Young Do, et al.
Publicado: (2015)

Structures of HIV-1-Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design
por: Gorman, Jason, et al.
Publicado: (2015)

Iterative structure-based improvement of a respiratory syncytial virus fusion glycoprotein vaccine
por: Joyce, M. Gordon, et al.
Publicado: (2016)

Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus
por: Boyington, Jeffrey C., et al.
Publicado: (2016)

Protection of calves by a prefusion-stabilized bovine RSV F vaccine
por: Zhang, Baoshan, et al.
Publicado: (2017)

Synthetic glycopeptides reveal the glycan specificity of HIV-neutralizing antibodies
por: Amin, Mohammed N., et al.
Publicado: (2013)

Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding
por: He, Linling, et al.
Publicado: (2014)

Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability
por: Mason, Rosemarie D., et al.
Publicado: (2016)

Correction: Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability
por: Mason, Rosemarie D., et al.
Publicado: (2016)

Structural Features of Antibody-Peptide Recognition
por: Lee, Jessica H., et al.
Publicado: (2022)

Cumulative Dose of Prostaglandin E1 Determines Gastrointestinal Adverse Effects in Term and Near-Term Neonates Awaiting Cardiac Surgery: A Retrospective Cohort Study
por: Ofek Shlomai, Noa, et al.
Publicado: (2023)

Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers
por: Hessell, Ann J., et al.
Publicado: (2009)

Glycosylator: a Python framework for the rapid modeling of glycans
por: Lemmin, Thomas, et al.
Publicado: (2019)

Elderly African Americans: The vulnerable of the vulnerable in the COVID‐19 era
por: Bhandari, Sanjay, et al.
Publicado: (2020)

The Human Vaccines Project: Towards a comprehensive understanding of the human immune response to immunization
por: Wooden, Stacey L., et al.
Publicado: (2018)

The potential use of liposome-mediated antiviral therapy
por: Koff, Wayne C., et al.
Publicado: (1985)

Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
por: Huang, Jinghe, et al.
Publicado: (2012)

Structure of an N276-Dependent HIV-1 Neutralizing Antibody Targeting a Rare V5 Glycan Hole Adjacent to the CD4 Binding Site
por: Wibmer, Constantinos Kurt, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_d201d58379l526bhie2hb3oitq